Oppenheimer Raises Price Target on Global Payments (GPN) Following Solid 2Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Pre-Open Stock Movers 01/09: (ARIA) (MACK) (WOOF) Higher; (ADHD) (AYI) (BABY) Lower (more...)
January 9, 2017 9:25 AM ESTARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) 73.4% HIGHER; Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) (ARIAD) today announced that they have entered into a definitive agreement under which Takeda will acquire all of the outstanding shares in ARIAD for $24.00 per share in cash, or an enterprise value of approximately $5.2 billion. The transaction has been approved unanimously by the boards of directors of both companies, and is expected to close by the end of February 2017, subject to required regulatory approvals and... More
Global Payments (GPN) Tops Q2 EPS by 5c; Raises Outlook
January 9, 2017 7:00 AM ESTGlobal Payments (NYSE: GPN) reported Q2 EPS of $0.89, $0.05 better than the analyst estimate of $0.84. Revenue for the quarter came in at $817.2 million versus the consensus estimate of $803.55 million.
GUIDANCE:
Global Payments sees FY2017 EPS of $3.70-$3.90, versus the consensus of $3.51. Global Payments sees FY2017 revenue of $3.35-3.45 billion, versus the consensus of $3.25... More
